Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure
DM Kaye,
GW Lambert,
J Lefkovits,
M Morris,
G Jennings,
and
MD Esler
Alfred and Baker Medical Unit, Baker Medical Research Institute, Melbourne, Australia.
OBJECTIVES. The aim of this study was to characterize cardiac sympathetic nervous function in patients with severe heart failure and to investigate the influence of the cause of heart failure, hemodynamic variables and central nervous system catecholamine release on cardiac sympathetic tone. BACKGROUND. Although heart failure is generally accompanied by sympathoexcitation, the integrity of cardiac sympathetic nerve function in heart failure remains controversial, particularly in relation to nerve firing activity and to the capacity of sympathetic nerves to recapture norepinephrine. Additionally, the location of the afferent and central neural pathways implicated in heart failure-induced sympathoexcitation remains unclear. METHODS. Radiotracer techniques were applied in 41 patients with severe heart failure and 15 healthy control subjects to study the biochemical aspects of whole body and cardiac sympathetic activity. Hemodynamic indexes of cardiac performance were measured in the heart failure group, and their association with sympathetic activity was studied. Jugular venous catechol spillover was measured to study the central noradrenergic control of sympathetic outflow. RESULTS. Sympathoexcitation was evident in the heart failure group, reflected by a 62% increase (p < 0.001) in total body and a 277% increase (p < 0.001) in cardiac norepinephrine spillover rates. These changes were accompanied by significant increases in the cardiac spillover of the norepinephrine precursor dihydroxyphenylalanine, the sympathetic cotransmitter neuropeptide Y and the extraneuronal metabolite 3-methoxy-4-hydroxyphenylglycol. The level of cardiac sympathetic activity was significantly correlated (r = 0.59, p < 0.001) with the mean pulmonary artery pressure. An increase in the spillover of dihydroxyphenylalanine and 3-methoxy-4-hydroxyphenylglycol from the brain was present, suggesting activation of central noradrenergic neurons. CONCLUSIONS. Cardiac sympathetic activation is present in severe heart failure, bearing a close relation with pulmonary artery pressures, independent of heart failure etiology. Activation of noradrenergic neurons in the brain is also present and may be the underlying central nervous mechanism of the sympathoexcitation observed in heart failure.
This article has been cited by other articles:

|
 |

|
 |
 
J. S. Floras
Sympathetic nervous system activation in human heart failure: clinical implications of an updated model.
J. Am. Coll. Cardiol.,
July 28, 2009;
54(5):
375 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Grassi, G. Bolla, F. Quarti-Trevano, F. Arenare, G. Brambilla, and G. Mancia
Sympathetic activation in congestive heart failure: Reproducibility of neuroadrenergic markers
Eur J Heart Fail,
December 1, 2008;
10(12):
1186 - 1191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ramchandra, S. G. Hood, A. M. D. Watson, and C. N. May
Responses of cardiac sympathetic nerve activity to changes in circulating volume differ in normal and heart failure sheep
Am J Physiol Regulatory Integrative Comp Physiol,
September 1, 2008;
295(3):
R719 - R726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Olson, A. M. Arruda-Olson, V. K. Somers, C. G. Scott, and B. D. Johnson
Exercise Oscillatory Ventilation*: Instability of Breathing Control Associated With Advanced Heart Failure
Chest,
February 1, 2008;
133(2):
474 - 481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fenton and M. Burch
Understanding chronic heart failure
Arch. Dis. Child.,
September 1, 2007;
92(9):
812 - 816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. D. Watson, S. G. Hood, R. Ramchandra, R. M. McAllen, and C. N. May
Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex
Am J Physiol Heart Circ Physiol,
July 1, 2007;
293(1):
H798 - H804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ciarka, J.-L. Vachiery, A. Houssiere, M. Gujic, E. Stoupel, S. Velez-Roa, R. Naeije, and P. van de Borne
Atrial Septostomy Decreases Sympathetic Overactivity in Pulmonary Arterial Hypertension
Chest,
June 1, 2007;
131(6):
1831 - 1837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.A. Gould, J. D'Agostino, H.G. Schneider, and D.M. Kaye
Influence of atrial fibrillation on cardiac brain natriuretic peptide release during haemodynamic stress in heart failure
Eur J Heart Fail,
May 1, 2006;
8(3):
263 - 269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Gould, M. Yii, M. D. Esler, J. M. Power, and D. M. Kaye
Atrial fibrillation impairs cardiac sympathetic response to baroreceptor unloading in congestive heart failure
Eur. Heart J.,
December 1, 2005;
26(23):
2562 - 2567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
The ESCAPE Investigators and ESCAPE Study Coordina
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness: The ESCAPE Trial
JAMA,
October 5, 2005;
294(13):
1625 - 1633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kaye and M. Esler
Sympathetic neuronal regulation of the heart in aging and heart failure
Cardiovasc Res,
May 1, 2005;
66(2):
256 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Kaye, B. Smirk, S. Finch, C. Williams, and M. D. Esler
Interaction between cardiac sympathetic drive and heart rate in heart failure: Modulation by adrenergic receptor genotype
J. Am. Coll. Cardiol.,
November 16, 2004;
44(10):
2008 - 2015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Oda, H. Asanoi, H. Ueno, K. Yamada, S. Joho, T. Kameyama, T. Hirai, T. Nozawa, S. Takashima, and H. Inoue
Pulse-synchronous sympathetic burst power as a new index of sympathoexcitation in patients with heart failure
Am J Physiol Heart Circ Physiol,
October 1, 2004;
287(4):
H1821 - H1827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Velez-Roa, M. Renard, J.-P. Degaute, and P. van de Borne
Peripheral sympathetic control during dobutamine infusion: effects of aging and heart failure
J. Am. Coll. Cardiol.,
November 5, 2003;
42(9):
1605 - 1610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A Gould, M. D Esler, and D. M Kaye
Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failure
Eur. Heart J.,
September 2, 2003;
24(18):
1657 - 1662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. T. Leung, J. S. Floras, G. Lorenzi-Filho, F. Rankin, P. Picton, and T. D. Bradley
Influence of Cheyne-Stokes Respiration on Cardiovascular Oscillations in Heart Failure
Am. J. Respir. Crit. Care Med.,
June 1, 2003;
167(11):
1534 - 1539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Bradley and J. S. Floras
Sleep Apnea and Heart Failure: Part I: Obstructive Sleep Apnea
Circulation,
April 1, 2003;
107(12):
1671 - 1678.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mansfield, D. M. Kaye, H. Brunner La Rocca, P. Solin, M. D. Esler, and M. T. Naughton
Raised Sympathetic Nerve Activity in Heart Failure and Central Sleep Apnea Is Due to Heart Failure Severity
Circulation,
March 18, 2003;
107(10):
1396 - 1400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Aggarwal, M. D. Esler, M. J. Morris, G. Lambert, and D. M. Kaye
Regional Sympathetic Effects of Low-Dose Clonidine in Heart Failure
Hypertension,
March 1, 2003;
41(3):
553 - 557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.M. Kaye
Alterations in oxygen consumption and sympathetic nervous activity in heart failure: independent or associated mechanisms?
Eur. Heart J.,
May 2, 2002;
23(10):
764 - 766.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.F. Notarius, E.R. Azevedo, J.D. Parker, and J.S. Floras
Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure
Eur. Heart J.,
May 2, 2002;
23(10):
800 - 805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Aggarwal, M. D. Esler, G. W. Lambert, J. Hastings, L. Johnston, and D. M. Kaye
Norepinephrine Turnover Is Increased in Suprabulbar Subcortical Brain Regions and Is Related to Whole-Body Sympathetic Activity in Human Heart Failure
Circulation,
March 5, 2002;
105(9):
1031 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. T. LEUNG and T. DOUGLAS BRADLEY
Sleep Apnea and Cardiovascular Disease
Am. J. Respir. Crit. Care Med.,
December 15, 2001;
164(12):
2147 - 2165.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Drazner, J. E. Rame, L. W. Stevenson, and D. L. Dries
Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure
N. Engl. J. Med.,
August 23, 2001;
345(8):
574 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.P Brunner-La Rocca, M.D Esler, G.L Jennings, and D.M Kaye
Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure
Eur. Heart J.,
July 1, 2001;
22(13):
1136 - 1143.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Kenney, T. I. Musch, and M. L. Weiss
Renal sympathetic nerve regulation to heating is altered in rats with heart failure
Am J Physiol Heart Circ Physiol,
June 1, 2001;
280(6):
H2868 - H2875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Kaye, L. Johnston, G. Vaddadi, H. Brunner-LaRocca, G. L. Jennings, and M. D. Esler
Mechanisms of Carvedilol Action in Human Congestive Heart Failure
Hypertension,
May 1, 2001;
37(5):
1216 - 1221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Aggarwal, M. D. Esler, F. Socratous, and D. M. Kaye
Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure
J. Am. Coll. Cardiol.,
April 1, 2001;
37(5):
1246 - 1251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Lotze, S. Kaepplinger, A. Kober, B. M. Richartz, D. Gottschild, and H. R. Figulla
Recovery of the Cardiac Adrenergic Nervous System After Long-Term {beta}-Blocker Therapy in Idiopathic Dilated Cardiomyopathy: Assessment by Increase in Myocardial 123I-Metaiodobenzylguanidine Uptake
J. Nucl. Med.,
January 1, 2001;
42(1):
49 - 54.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. SOLIN, T. ROEBUCK, D. P. JOHNS, E. HAYDN WALTERS, and M. T. NAUGHTON
Peripheral and Central Ventilatory Responses in Central Sleep Apnea with and without Congestive Heart Failure
Am. J. Respir. Crit. Care Med.,
December 1, 2000;
162(6):
2194 - 2200.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. B. Sverrisdottir, B. Rundqvist, G. Johannsson, and M. Elam
Sympathetic Neural Burst Amplitude Distribution : A More Specific Indicator of Sympathoexcitation in Human Heart Failure
Circulation,
October 24, 2000;
102(17):
2076 - 2081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Azevedo, G. E. Newton, J. S. Floras, and J. D. Parker
Reducing Cardiac Filling Pressure Lowers Norepinephrine Spillover in Patients With Chronic Heart Failure
Circulation,
May 2, 2000;
101(17):
2053 - 2059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Kaye, G. Vaddadi, S. L. Gruskin, X.-J. Du, and M. D. Esler
Reduced Myocardial Nerve Growth Factor Expression in Human and Experimental Heart Failure
Circ. Res.,
April 14, 2000;
86
(7):
e80 - e84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Naredi, G. Lambert, E. Eden, S. Zall, M. Runnerstam, B. Rydenhag, and P. Friberg
Increased Sympathetic Nervous Activity in Patients With Nontraumatic Subarachnoid Hemorrhage
Stroke,
April 1, 2000;
31(4):
901 - 906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. G. Macefield, B. Rundqvist, Y. B. Sverrisdottir, B. G. Wallin, and M. Elam
Firing Properties of Single Muscle Vasoconstrictor Neurons in the Sympathoexcitation Associated With Congestive Heart Failure
Circulation,
October 19, 1999;
100(16):
1708 - 1713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Braith, M. A. Welsch, M. S. Feigenbaum, H. A. Kluess, and C. J. Pepine
Neuroendocrine activation in heart failure is modified by endurance exercise training
J. Am. Coll. Cardiol.,
October 1, 1999;
34(4):
1170 - 1175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sakotnik, P.M. Liebmann, K. Stoschitzky, P. Lercher, K. Schauenstein, W. Klein, and B. Eber
Decreased melatonin synthesis in patients with coronary artery disease
Eur. Heart J.,
September 2, 1999;
20(18):
1314 - 1317.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-J. Du, H. S. Cox, A. M. Dart, and M. D. Esler
Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure
Cardiovasc Res,
September 1, 1999;
43(4):
919 - 929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. Stevenson
Tailored therapy to hemodynamic goals for advanced heart failure
Eur J Heart Fail,
August 31, 1999;
1(3):
251 - 257.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Azevedo and J. D. Parker
Parasympathetic Control of Cardiac Sympathetic Activity : Normal Ventricular Function Versus Congestive Heart Failure
Circulation,
July 20, 1999;
100(3):
274 - 279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Grassi and G Mancia
Sympathetic overactivity and exercise intolerance in heart failure: a cause-effect relationship
Eur. Heart J.,
June 2, 1999;
20(12):
854 - 855.
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Kaye, A. M. Dart, G. L. Jennings, and M. D. Esler
Antiadrenergic effect of chronic amiodarone therapy in human heart failure
J. Am. Coll. Cardiol.,
May 1, 1999;
33(6):
1553 - 1559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Abramson, S.-i. Ando, C. F. Notarius, G. A. Rongen, and J. S. Floras
Effect of Atrial Natriuretic Peptide on Muscle Sympathetic Activity and Its Reflex Control in Human Heart Failure
Circulation,
April 13, 1999;
99(14):
1810 - 1815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Azevedo, G. E. Newton, and J. D. Parker
Cardiac and systemic sympathetic activity in response to clonidine in human heart failure
J. Am. Coll. Cardiol.,
January 1, 1999;
33(1):
186 - 191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Anzai, N. C. Lai, M. Gao, and H. K. Hammond
Dissociation between regional dysfunction and beta -adrenergic receptor signaling in heart failure
Am J Physiol Heart Circ Physiol,
October 1, 1998;
275(4):
H1267 - H1273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. B. Sverrisdóttir, M. Elam, H. Herlitz, B.-A. Bengtsson, and G. Johannsson
Intense Sympathetic Nerve Activity in Adults with Hypopituitarism and Untreated Growth Hormone Deficiency
J. Clin. Endocrinol. Metab.,
June 1, 1998;
83(6):
1881 - 1885.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Rundqvist, G. Eisenhofer, M. Elam, and P. Friberg
Attenuated Cardiac Sympathetic Responsiveness During Dynamic Exercise in Patients With Heart Failure
Circulation,
February 18, 1997;
95(4):
940 - 945.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Rundqvist, M. Elam, Y. Bergmann-Sverrisdottir, G. Eisenhofer, and P. Friberg
Increased Cardiac Adrenergic Drive Precedes Generalized Sympathetic Activation in Human Heart Failure
Circulation,
January 7, 1997;
95(1):
169 - 175.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. J. Morris, H. S. Cox, G. W. Lambert, D. M. Kaye, G. L. Jennings, I. T. Meredith, and M. D. Esler
Region-Specific Neuropeptide Y Overflows at Rest and During Sympathetic Activation in Humans
Hypertension,
January 1, 1997;
29(1):
137 - 143.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. E. Newton and J. D. Parker
Cardiac Sympathetic Responses to Acute Vasodilation: Normal Ventricular Function Versus Congestive Heart Failure
Circulation,
December 15, 1996;
94(12):
3161 - 3167.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Eisenhofer, P. Friberg, B. Rundqvist, A. A. Quyyumi, G. Lambert, D. M. Kaye, I. J. Kopin, D. S. Goldstein, and M. D. Esler
Cardiac Sympathetic Nerve Function in Congestive Heart Failure
Circulation,
May 1, 1996;
93(9):
1667 - 1676.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. H. H. Leenen, B. S. Huang, H. Yu, and B. Yuan
Brain `Ouabain' Mediates Sympathetic Hyperactivity in Congestive Heart Failure
Circ. Res.,
November 1, 1995;
77(5):
993 - 1000.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. J. Manolis, C. Olympios, M. Sifaki, S. Handanis, M. Bresnahan, I. Gavras, and H. Gavras
Suppressing Sympathetic Activation in Congestive Heart Failure : A New Therapeutic Strategy
Hypertension,
November 1, 1995;
26(5):
719 - 724.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. D. Parker, G. E. Newton, J. S. Landzberg, J. S. Floras, and W. S. Colucci
Functional Significance of Presynaptic {alpha}-Adrenergic Receptors in Failing and Nonfailing Human Left Ventricle
Circulation,
October 1, 1995;
92(7):
1793 - 1800.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. W. Lambert, D. M. Kaye, J. Lefkovits, G. L. Jennings, A. G. Turner, H. S. Cox, and M. D. Esler
Increased Central Nervous System Monoamine Neurotransmitter Turnover and Its Association With Sympathetic Nervous Activity in Treated Heart Failure Patients
Circulation,
October 1, 1995;
92(7):
1813 - 1818.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
X.-J. Du, M. D. Esler, and A. M. Dart
Sympatholytic Action of Intravenous Amiodarone in the Rat Heart
Circulation,
January 15, 1995;
91(2):
462 - 470.
[Abstract]
[Full Text]
|
 |
|
|